Katherine Rittenbach Publications

Select Publications

2024

• Barry R, Anderson J, Tran L, Bahji A, Dimitropoulos G, Ghosh SM, Kirkham J, Messier G, Patten SB, Rittenbach K, Seitz D. (2024). Prevalence of Mental Health Disorders Among Individuals Experiencing Homelessness: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 81(7):691-699.
• McLane P, Bill L, Healy B, Barnabe C, Plume TB, Bird A, Colquhoun A, Holroyd BR, Janvier K, Louis E, Rittenbach K, Curtin KD, Fitzpatrick KM, Mackey L, MacLean D, Rosychuk RJ. (2024). Leaving emergency departments without completing treatment among First Nations and non-First Nations patients in Alberta: a mixed-methods study. CMAJ. 196(15):E510-E523.
• Kim C, Bai Y, Allin S, Kirst M, O’Campo P, Ienciu K, Xia X, MacMaster F, Rittenbach K, Chum A. (2024). Cannabis legalization and hospitalizations in Alberta: Interrupted time series analysis by age and sex. J Addict Dis. 2024 May 19:1-4.

2023

• Soos B, Garies S, Cornect-Benoit A, Montgomery L, Sharpe H, Rittenbach K, Manca D, Duerksen K, Forst B, Drummond N. (2023). Documenting cannabis use in primary care: a descriptive cross-sectional study using electronic medical record data in Alberta, Canada. BMC Res Notes. 16(1):9.
• Wine O, McNeil D, Kromm SK, Foss K, Caine V, Clarke D, Day N, Johnson DW, Rittenbach K, Wood S, Hicks M. (2023). The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT (NASCENT) program: protocol for a stepped wedge cluster randomized trial of a hospital-level Neonatal Abstinence Syndrome rooming-in intervention. BMC Health Serv Res. 23(1):448.
• Kim C, Dusing GJ, Nielsen A, MacMaster FP, Rittenbach K, Allin S, O’Campo P, Penney TL, Hamilton HA, Kirst M, Chum A. (2023). Disparities in cannabis-related emergency department visits across depressed and non-depressed individuals and the impact of recreational cannabis policy in Ontario, Canada. Psychol Med. 53(15):7127-7137.
• Ferguson M, Rittenbach K, Leece P, Adams A, Ali F, Elton-Marshall T, Burmeister C, Brothers TD, Medley A, Choisil P, Strike C, Ng J, Lorenzetti DL, Gallant K, Buxton JA; le groupe d’élaboration des documents d’orientation relative à la naloxone pour. (2023). Document d’orientation sur la distribution et l’utilisation de trousses de naloxone à emporter par les intervenants et intervenantes communautaires en cas de surdose au Canada. CMAJ. 195(38):E1312-E1325. French.
• Ferguson M, Rittenbach K, Leece P, Adams A, Ali F, Elton-Marshall T, Burmeister C, Brothers TD, Medley A, Choisil P, Strike C, Ng J, Lorenzetti DL, Gallant K, Buxton JA; Naloxone Guidance Development Group. (2023).Guidance on take-home naloxone distribution and use by community overdose responders in Canada. CMAJ. 195(33):E1112-E1123.

2022

• Andrews CN, Rehak R, Woo M, Walker I, Ma C, Forbes N, Rittenbach K, Hathaway J, Wilsack L, Liu A, Nasser Y, Sharkey KA. (2022). Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence. Aliment Pharmacol Ther. 56(11-12):1532-1542.
• Milaney K, Haines-Saah R, Farkas B, Egunsola O, Mastikhina L, Brown S, Lorenzetti D, Hansen B, McBrien K, Rittenbach K, Hill L, O’Gorman C, Doig C, Cabaj J, Stokvis C, Clement F. (2022). A scoping review of opioid harm reduction interventions for equity-deserving populations. Lancet Reg Health Am. 12:100271.
• McLane P, Mackey L, Holroyd BR, Fitzpatrick K, Healy C, Rittenbach K, Plume TB, Bill L, Bird A, Healy B, Janvier K, Louis E, Barnabe C. (2022).  Impacts of racism on First Nations patients’ emergency care: results of a thematic analysis of healthcare provider interviews in Alberta, Canada. BMC Health Serv Res. 21;22(1):804.
• Ferguson M, Medley A, Rittenbach K, Brothers TD, Strike C, Ng J, Leece P, Elton-Marshall T, Ali F, Lorenzetti DL, Buxton JA. (2022). Priority setting for Canadian Take-Home Naloxone best practice guideline development: an adapted online Delphi method. Harm Reduct J. 2;19(1):71.
• Kim C, Chum A, Nielsen A, Allin S, Penney TL, Rittenbach K, MacMaster FP, O’Campo P. (2022). Associations between recreational cannabis legalization and cannabis-related emergency department visits by age, gender, and geographic status in Ontario, Canada: An interrupted time series study. PLoS One. 17(10):e0268718.
• Kim C, Chum A, Nielsen A, MacMaster F, Rittenbach K, Allin S, O’Campo P, Kirst M, Hamilton H. (2022). Cannabis Legalization and cannabis-Related Hospitalizations in Ontario, Canada. Can J Psychiatry. 27:7067437221114785. doi: 10.1177/07067437221114785.
• Williamson N, Hathaway J, Jahrig J, Vik S, Rittenbach K. (2022). Cannabis use and concern among clients seeking substance misuse treatment: demographics, comorbidities, and service utilization patterns pre-legalization (2012-2018). Canadian Journal of Addiction 13(1): 19-26.

2021

• Marshall T, Hancock M, Kinnard EN, Olson K, Abba-Aji A, Rittenbach K, Stea JN, Tanguay R, Vohra S. (2021). Treatment options and shared decision-making in the treatment of opioid use disorder: A scoping review. J Subst Abuse Treat. 135:108646. doi: 10.1016/j.jsat.2021.108646.
• Deschamps J, Gilbertson J, Straube S, Dong K, MacMaster FP, Korownyk C, Montgomery L, Mahaffey R, Downar J, Clarke H, Muscedere J, Rittenbach K, Featherstone R, Sebastianski M, Vandermeer B, Lynam D, Magnussen R, Bagshaw SM, Rewa OG. (2021).  Association between supportive interventions and healthcare utilization and outcomes in patients on long-term prescribed opioid therapy presenting to acute healthcare settings: a systematic review and meta-analysis. BMC Emerg Med. 21(1):17. doi: 10.1186/s12873-020-00398-9.
• Moustaqim-Barrette, A., Dhillon, D., Ng J., Sundvick, K., Ali, F., Elton-Marshall, T., Leece, P., Rittenbach, K., Ferguson, M., Buxton, J.A. (2021). Take-home naloxone programs for
  suspected opioid overdose in community settings: a scoping umbrella review. BMC Public Health. 21:597.
• Bristowe, S., Ghosh, S., Trew, M., CMHA., Rittenbach, K. (2021). Virtual Overdose Response for People Who Use Opioids Alone: Protocol for a Feasibility and Clinical Trial Study. JMIR Res Protoc. 12;10(5):e20183.

2019

• Rittenbach K, MacMaster FP, Mitchell N; Addiction and Mental Health Strategic Clinical Network. (2019). Addiction and Mental Health Strategic Clinical Network: Involving people with lived experience to transform care in Alberta. CMAJ. 4;191(Suppl):S7-S9. doi: 10.1503/cmaj.190586.
• Palay J, Taillieu TL, Afifi TO, Turner S, Bolton JM, Enns MW, Smith M, Lesage A, Bakal JA, Rush B, Adair CE, Vigod SN, Clelland S, Rittenbach K, Kurdyak P, Sareen J. (2019). Prevalence of Mental Disorders and Suicidality in Canadian Provinces. Can J Psychiatry. 64(11):761-769. doi: 10.1177/0706743719878987.
• Deschamps J, Gilbertson J, Straube S, Dong K, MacMaster FP, Korownyk C, Montgomery L, Mahaffey R, Downar J, Clarke H, Muscedere J, Rittenbach K, Featherstone R, Sebastianski M, Vandermeer B, Lynam D, Magnussen R, Bagshaw SM, Rewa OG. (2019). Association between harm reduction strategies and healthcare utilization in patients on long-term prescribed opioid therapy presenting to acute healthcare settings: a protocol for a systematic review and meta-analysis. Syst Rev. 5;8(1):88. doi: 10.1186/s13643-019-0997-5.
• Yan, C., Rittenbach, K., Souri, S., Silverstone, P.H. (2019). Cost-Effectiveness Analysis of a Randomized Study of Depression Treatment Options in Primary Care Suggests Stepped-Care Treatment may Have Economic Benefits. BMC Psychiatry. 19:240.
• Brown, S., Rittenbach, K., Cheung, S., McKean, G., MacMaster, F.P., Clement, F. (2019). Current and Common Definitions of Treatment Resistant Depression: Findings from a Systematic Review and Qualitative Interviews. Canadian Journal of Psychiatry.

2018

• Breault, L.J., Rittenbach, K., Hartle, K., Babins-Wagner, R., deBeaudrap, C., Jasaui, Y., Ardell, E., Purdon, S.E., Michael, A., Sullivan, G., Unger, S.R., Vandall-Walker, L., Necyk, B., Krawec, K., Manafo, E., Mason-Lai, P. (2018). People with lived experience (PWLE) of depression: describing and reflecting on an explicit patient engagement process within depression research priority setting in Alberta, Canada. Research Involvement and Engagement. 4:37.
• Marshall, T., Kinnard, E.N., Hancock, M., Jones, S.K., Olson, K., Abba-Aji, A., Rittenbach, K., Vohra, S. (2018). Patient Engagement, Treatment Preferences and Shared Decision-Making (SDM) in the Treatment of Opioid Use Disorder (OUD) in Adults: A Scoping Review Protocol. British Medical Journal Open 8(10), e022267.
• Breault, L.J., Rittenbach, K., Hartle, K., Babins-Wagner, R., deBeaudrap, C., Jasaui, Y., Ardell, E., Purdon, S.E., Michael, A., Sullivan, G., Unger, S.R., Vandall-Walker, L., Necyk, B., Krawec, K., Manafo, E., Mason-Lai, P. (2018). The top research questions asked by people with lived depression experience in Alberta: a survey. Canadian Medical Association Journal Open. 6(3) E398-E405.

2017

• Freeman, L.K., Bourque, S., Etches, N., Goodison, K., O’Gorman, C., Rittenbach, K., Sikora, C.A., Yarema, M. (2017). Alberta’s provincial take-home naloxone program: A multi-sectoral and multi-jurisdictional response to overdose. Canadian Journal of Public Health. 108(4):e398-e402.
• Silverstone, P.H., Bercov, M., Suen, V.Y.M., Allen, A., Cribben, I., Goodrick, J., Henry, S., Pryce, C., Langstraat, P., Rittenbach, K., Chakraborty, S., Engels, R.C., McCabe, C. (2017). Long-term results from the EMPATHY program, a multimodal school-based approach, show marked reductions in suicidality, depression, and anxiety in 6,227 students in Grades 6-12 (aged 11-18). Frontiers in Psychiatry – Child and Adolescent Psychiatry.
• MacMaster, F.P., Swansburg, R., Rittenbach, K.A. (2017). Academic productivity in psychiatry: benchmarks for the H-index. Academic Psychiatry.
• Silverstone, P.H., Rittenbach, K.A., Suen, V.Y.M., Moretzohn, A., Cribben, I., Bercov, M., Allen, A., Pryce, C., Hamza, D.M., Trew, M. (2017). Depression outcomes in adults attending family practice were not improved by screening, stepped-care, or on-line CBT during a 12-week study when compared to controls in a randomized trial. Frontiers in Psychiatry – Mood and Anxiety.

2016

• MacMaster, F.P., Cohen, J., Waheed, W., Maguad, E., Swanburg, R.M. & Rittenbach, K.A. (2016). Psychiatry resident and program director perceptions of neuroscience. Medical Science Educator.
• Silverstone, P.H., Suen, V.Y.M., Ashton, C.K., Hamza, D.M., Martin, E.K. & Rittenbach, K.A. (2016). Are complex multimodal interventions the best treatments for mental health disorders in children and youth? Journal of Child & Adolescent Behavior. 4(4).